loadpatents
name:-0.018085956573486
name:-0.013201951980591
name:-0.0048830509185791
FARNABY; William Patent Filings

FARNABY; William

Patent Applications and Registrations

Patent applications and USPTO patent grants for FARNABY; William.The latest application filed is for "pyridazinone compounds and their use as daao inhibitors".

Company Profile
4.13.19
  • FARNABY; William - Cambridge GB
  • FARNABY; William - St. Andrews Fife
  • Farnaby; William - Cambridgeshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20220008416 - FARNABY; William ;   et al.
2022-01-13
Proteolysis Targeting Chimera (protacs) As Degraders Of Smarca2 And /or Smarca4
App 20210380579 - CIULLI; Alessio ;   et al.
2021-12-09
Pyridazinone compounds and their use as DAAO inhibitors
Grant 11,129,828 - Farnaby , et al. September 28, 2
2021-09-28
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20200121678 - FARNABY; William ;   et al.
2020-04-23
Pyridazinone compounds and their use as DAAO inhibitors
Grant 10,463,663 - Farnaby , et al. No
2019-11-05
Amide derivatives as lysophosphatidic acid receptor antagonists
App 20190010129 - Buffham; William ;   et al.
2019-01-10
Amide derivatives as lysophosphatidic acid receptor antagonists
Grant 10,100,018 - Buffham , et al. October 16, 2
2018-10-16
Pyrimidinone compounds and their use
Grant 10,085,986 - Cockcroft , et al. October 2, 2
2018-10-02
3-substituted 2-amino-indole derivatives
Grant 10,059,713 - Barker , et al. August 28, 2
2018-08-28
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20180177780 - FARNABY; William ;   et al.
2018-06-28
Pyridazinone compounds and their use as DAAO inhibitors
Grant 9,931,340 - Farnaby , et al. April 3, 2
2018-04-03
1,3-substituted 2-amino-indole Derivatives And Analogues Useful In The Treatment Or Prevention Of Diabetes Mellitus, Obesity, And Inflammatory Bowel Disease
App 20170369492 - DAVENPORT; Richard ;   et al.
2017-12-28
Pyridazinones as DAAO enzyme inhibitors
Grant 9,750,748 - Farnaby , et al. September 5, 2
2017-09-05
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20170173007 - FARNABY; William ;   et al.
2017-06-22
3-substituted 2-amino-indole Derivatives
App 20170158700 - BARKER; Gregory ;   et al.
2017-06-08
Compounds
Grant 9,464,060 - Buffham , et al. October 11, 2
2016-10-11
Amide Derivatives As Lysophosphatidic Acid Receptor Antagonists
App 20160207880 - BUFFHAM; William ;   et al.
2016-07-21
Pyridazinone compounds and their use as DAAO inhibitors
Grant 9,290,456 - Farnaby , et al. March 22, 2
2016-03-22
Pyridazinones As Daao Enzyme Inhibitors
App 20150329495 - FARNABY; William ;   et al.
2015-11-19
5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain
Grant 9,180,122 - Farnaby , et al. November 10, 2
2015-11-10
Novel Compounds
App 20150057298 - BUFFHAM; William ;   et al.
2015-02-26
Pyridazinone Compounds And Their Use As Daao Inhibitors
App 20150030704 - Farnaby; William ;   et al.
2015-01-29
Pyrimidinone Compounds And Their Use
App 20140248378 - Cockcroft; Xiao-Ling Fan ;   et al.
2014-09-04
5- Or 6-substituted 3-hydroxy-2(1h)-pyridinones As D-amino Acid Oxidase (daao) Inhibitors In Therapy Of Diseases Such As Schizophrenia, Cognitive Disorder And Paid
App 20140243353 - Farnaby; William ;   et al.
2014-08-28
Novel Compounds
App 20130052281 - FARNABY; William ;   et al.
2013-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed